SKHHY SONIC HEALTHCARE SPON ADR EACH REP 1 ORD SHS
- 17.405
- +0.165+0.96%
SONIC HEALTHCARE SPON ADR EACH REP 1 ORD SHS News
Sonic Healthcare Limited Goes Ex Dividend Tomorrow
Sonic Healthcare Limited Reports H1 Results
SONIC HEALTHCARE SPON ADR EACH REP 1 ORD SHS To Go Ex-Dividend On March 1st, 2024 With 0.28199 USD Dividend Per Share
February 21st - $SONIC HEALTHCARE SPON ADR EACH REP 1 ORD SHS(SKHHY.US)$ is trading ex-dividend on March 1st, 2024. Shareholders of record on March 4th, 2024 will receive 0.28199 USD dividend per
SONIC HEALTHCARE SPON ADR EACH REP 1 ORD SHS To Go Ex-Dividend On September 5th, 2023 With 0.39773 USD Dividend Per Share
August 22nd - $SONIC HEALTHCARE SPON ADR EACH REP 1 ORD SHS(SKHHY.US)$ is trading ex-dividend on September 5th, 2023. Shareholders of record on September 6th, 2023 will receive 0.39773 USD dividen
Weekly Top 10 Gainers & Losers (Feb 13 - Feb 17)
Check out the top gainers and losers in the US market.
U.S. allows monkeypox testing at commercial labs - Washington Post
The Biden administration said Wednesday that commercial laboratories would be allowed to conduct monkeypox tests as the U.S. rushes to contain the outbreak that is believed to be far bigger than the o
Sonic Healthcare, Healius Near Earnings Peak -- Market Talk
2323 GMT--Credit Suisse forecasts peak earnings for both Sonic Healthcare and Healius in 1H of FY 2022, driven by strong demand for PCR testing. "However, we see risk to 2H consensus earnings with
Sonic Healthcare Acquires Texas-Based Anatomical Pathology Company
09:18 PM EST, 12/16/2021 (MT Newswires) -- Sonic Healthcare (ASX:SHL) acquired Dallas, Texas-based anatomical pathology company ProPath. ProPath has an annual revenue of $110 million and serves over
Quest Diagnostics Inc. Stock Rises Wednesday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) rallied 1.72% to $151.24 Wednesday, on what proved to be
Quest Diagnostics Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) advanced 1.13% to $156.70 Monday, on what proved to be a
Australian Pathology Stocks Rise Amid Omicron Worries -- Market Talk
0345 GMT - Shares in Australian pathology firms Sonic Healthcare and Healius are higher even as worries over the impact of the Omicron coronavirus variant unsettle the local equities market. Sha
Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) slipped 1.01% to $149.52 Wednesday, on what proved to be
Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) inched 0.20% higher to $151.04 Tuesday, on what proved t
Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) rose 1.94% to $144.78 Wednesday, on what proved to be an
Quest Diagnostics Inc. Stock Falls Tuesday, Still Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) shed 0.13% to $142.03 Tuesday, on what proved to be an a
Global Clinical In Vitro Diagnostic Medical Laboratory Services Market to 2026: Diagnostic Technology Development - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market 2022 - 2026: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Micr
Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) shed 2.09% to $144.23 Tuesday, on what proved to be an a
Quest Diagnostics Inc. Stock Rises Monday, Outperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) inched 0.36% higher to $147.31 Monday, on what proved to
Quest Diagnostics Inc. Stock Falls Wednesday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) slipped 1.07% to $143.94 Wednesday, on what proved to be
Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of Quest Diagnostics Inc. (DGX) slid 1.01% to $145.01 Monday, on what proved to be an al
Analysis
Price Target
No Data
